Thirty percent of women and men who are diagnosed with breast cancer will eventually develop stage 4 (metastatic) breast cancer and die. Yet of all the money dedicated to breast cancer research, only 2% is earmarked specifically for metastatic research. METAvivor’s goal is to have cancer organizations devote 30% of their research budget to research that will help the 30% of women and men whose cancer metastasizes.

The surest way to save the lives of patients already diagnosed with breast cancer is to find a way to make MBC survivable.


METAvivor is dedicated to the specific fight of women and men living with stage 4 metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research. While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual stage 4 breast cancer research.

Read our brochure to learn more about METAvivor.

METAvivor exists to sustain hope for those living with stage 4 metastatic breast cancer (MBC). We are a volunteer-led, non-profit organization that funds vital research to help improve the longevity and quality of life for MBC patients. Passionately committed patients ourselves, we rally public attention to the urgent needs of the MBC community, help patients find strength through support and purpose, and make every dollar count as we work with researchers to extend and improve quality of life for MBC patients.

About Us

Pink ribbons are all around us in October and April announcing the seasons of Breast Cancer “awareness” throughout the country. Hundreds of millions of dollars are raised nationally for Breast Cancer, but a very small portion of this money is being allocated for Metastatic Breast Cancer (MBC). And while there is plenty of giving going on, there are very few advocates and organizations for MBC. One of our national outspoken advocates is Kelli Parker of Bella Vista, Arkansas. She was diagnosed at 26 with stage 1 breast cancer and metastasized to stage 4 by the age of 33. She did everything the early detection/awareness campaigns said she was supposed to do—double mastectomy, chemotherapy, radiation, hysterectomy, hormonal therapy, and more. Kelli realized that the current awareness and early detection approach is not working and is fighting for Metastatic Breast Cancer patients around the country and world.

Read More…